Posted on August 27, 2011 by Sitemaster
Researchers at the Mayo Clinic have queried their large, nearly 20-year-long database of men who have undergone radical prostatectomy in an attempt to assess the correlation between positive surgical margins at the time of surgery and subsequent occurence of systemic disease or prostate cancer-specific mortality. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: outcome, positive surgical margins, prostate cancer-specific mortality, radical prostatectomy, systemic disease | 4 Comments »
Posted on January 19, 2011 by Sitemaster
According to an editorial commentary by Evans on the UroToday web site yesterday, a Canadian study published in BJU International last November has raised some interesting questions about the potential value of pelvic lymph node dissection (PLND) during the surgical treatment of men with prostate cancer of any stage. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: outcome, pelvic lymph node dissection, PLND, prostate cancer-specific mortality | 1 Comment »
Posted on October 27, 2010 by Sitemaster
A presentation to be given next week at the upcoming annual meeting of the American Society for Radiation Oncology (ASTRO) will suggest that men initially diagnosed with localized prostate cancer and who take an anti-clotting agent are at significantly lower risk for prostate cancer-specific death at 10 years of follow-up. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: anti-clotting agent, aspirin, prostate cancer-specific mortality, risk | 2 Comments »
Posted on October 8, 2010 by Sitemaster
According to a report yesterday in Consumer Affairs, “American men with prostate cancer were 45 percent less likely to die from the disease in 2006 than they were in 1999.” … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: decline, PCSM, prostate cancer-specific mortality | 10 Comments »
Posted on August 10, 2010 by Sitemaster
It is not exactly news that men who are diagnosed with localized prostate cancer, but who have a significant number of comorbid conditions, are actually at relatively low risk of prostate cancer-specific mortality. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: outcome, PCSM, prognosis, prostate cancer-specific mortality, questionnaire, survey, TIBI-CaP | 5 Comments »